A discussion of how patients are chosen to participate in clinical trials, and how people can inform themselves about the risks and outcomes of participating in tests of new drugs and medical treatments.


  • Dr. John Gallin Director of the Clinical Center at the National Institutes of Health
  • Jane Reese Colburn National Cancer Institute consultant
  • Terry Toigo Food and Drug Administration Office of Special Health Issues
  • Pat Barr Past board member of the National Breast Cancer Coalition and founder of the Breast Cancer Network in Vermont


comments powered by Disqus
Most Recent Shows

The Tuskegee Study, 50 Years Later

Friday, Jul 29 2022Fifty years after the Tuskegee study, Diane talks to Harvard's Evelynn Hammonds about the intersection of race and medicine in the United States, and the lessons from history that can help us understand health inequities today.

Jan. 6 And The Ongoing Threat Of Right-Wing Extremism

Friday, Jul 15 2022What's happened to groups like the Oath Keepers and Proud Boys post-January 6, and the ongoing threat of far-right extremism in this country. Diane talks to Sam Jackson, author of "Oath Keepers: Patriotism and the Edge of Violence in a Right-Wing Antigovernment Group"